{"id":"W3213252676","doi":"10.25251/skin.5.supp.37","title":"Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor, Compared With Placebo and Apremilast in Moderate to Severe Psoriasis: Integrated Laboratory Parameter Results From the Phase 3 POETYK PSO-1 and POETYK PSO-2 Trials","year":2021,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Bristol-Myers Squibb","keywords":"Apremilast; Placebo; Psoriasis; Medicine; Internal medicine; Pharmacology; Dermatology; Psoriatic arthritis; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001268722,0.0007089485,0.002306164,0.0002664954,0.000199535,0.0007719278,0.0004332204,0.0006800487,0.004123165],"category_scores_gemma":[0.00110477,0.0002418673,0.001513409,0.0002921673,0.0003707144,0.0007595891,0.0001911783,0.001548712,0.0005311759],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004932257,"about_ca_system_score_gemma":0.0005151589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007766467,"about_ca_topic_score_gemma":0.002405837,"domain_scores_codex":[0.9995137,0.0002494511,0.00004534048,0.00006724677,0.00005841598,0.00006574678],"domain_scores_gemma":[0.9994041,0.0002015116,0.0001584675,0.00003269563,0.00003996889,0.00016338],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8929567,0.002613622,0.00130341,0.001298723,0.002443474,0.00003545759,0.00003312944,0.0005059228,0.00921832,0.00008604662,0.002183272,0.08732185],"study_design_scores_gemma":[0.7461728,0.21104,0.02679948,0.0002107056,0.004811218,0.0002855649,0.00008189728,0.001462341,0.004387115,0.0003098722,0.004387318,0.00005157252],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9539288,0.03643141,0.0006352387,0.0009495211,0.0004541773,0.0006561503,0.002009599,0.0001962035,0.004738842],"genre_scores_gemma":[0.9859189,0.008703038,0.0006114438,0.0005615081,0.0002804855,0.0003289155,0.001450848,0.00002093432,0.002124029],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004123165,"threshold_uncertainty_score":0.01379329,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0246529517252897,"score_gpt":0.2993854296567134,"score_spread":0.2747324779314237,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}